4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride CAS 106261-49-8 Imatinib Mesylate Intermediate High Bohloeki
Tlhahiso ea Khoebo ea Imatinib Mesylate le Li-Intermediates tse Amanang:
Imatinib Mesylate CAS: 220127-57-1
N-(2-Methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine CAS: 152460-09-8
N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidinea CAS: 152460-10-1
4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride CAS: 106261-49-8
Lebitso la Lik'hemik'hale | 4- [(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride |
Litlhaloso tse tšoanang | Imatinib Mesylate ea Mahareng |
Nomoro ea CAS | 106261-49-8 |
Nomoro ea KAtse | RF-PI229 |
Boemo ba Setoko | Ka Setokong, Sekhahla sa Tlhahiso Ho fihlela ho Lithane |
Foromo ea limolek'hule | Setšoantšo sa C13H20Cl2N2O2 |
Boima ba Molek'hule | 307.22 |
Melting Point | 305.0~307.0℃ |
Solubility | E qhibilihang ka Metsing |
Brand | Ruifu Chemical |
Ntho | Litlhaloso |
Ponahalo | Bosoeu ho isa ho Phofo e Batlileng e Tšoeu ho isa ho Crystal |
Mokhoa oa Bohloeki / Analysis | ≥98.0% (HPLC) |
Tahlehelo ka ho Omisa | ≤0.50% |
Masalla ha a tuka | ≤0.50% |
Litšila ka Kakaretso | ≤2.0% |
Ho se hloeke ho hoholo ho le Mong | ≤1.0% |
Tekanyetso ea Teko | Maemo a Khoebo |
Tšebeliso | Pharmaceutical Intermediate of Imatinib Mesylate (CAS: 220127-57-1) |
Sephutheloana: Botlolo, Aluminium foil bag, Cardboard drum, 25kg/Drum, kapa ho latela tlhoko ea moreki.
Boemo ba polokelo:Boloka ka lijaneng tse koetsoeng sebakeng se phodileng le se omileng;Sireletsa khanya, mongobo le ho hlaseloa ke likokoanyana.
Shanghai Ruifu Chemical Co., Ltd. ke moetsi ea ka sehloohong le mofani oa thepa ea 4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride (CAS: 106261-49-8) e nang le boleng bo phahameng.Eonake ea mahareng ka tloaelo ho motsoako oa Imatinib Mesylate (CAS: 220127-57-1).Imatinib Mesylate ke tyrosine kinase inhibitor, e khethehileng haholo bakeng sa BCR-ABL, setlhare sa molomo bakeng sa phekolo ea bakuli ba baholo ba nang le Philadelphia chromosome positive chronic myeloid leukemia (CML) in the acute phase le mefuta e meng ea acute lymphoblastic leukemia (ALL), e potlakile. mohato le mohato o sa foleng ka mor'a ho hlōleha ha phekolo ea interferon.